Status:
NOT_YET_RECRUITING
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
Lead Sponsor:
Zhixin Cao
Conditions:
Gastric Cancer
Peritoneal Metastases
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
Patients with stage cT3-4N+M0 gastric cancer were recommended to receive neoadjuvant chemotherapy before radical surgery in terms of the eradication of micrometastasis in addition to local control, hi...
Eligibility Criteria
Inclusion
- histologically proven adenocarcinoma of stomach
- stage cT3-4N+M0
- no involvement of esophagus \> 3 cm
- ECOG (Eastern Cooperative Oncology Group) : 0\~1
- no previous chemotherapy or radiotherapy for any malignancy
- no previous surgery for GC excluding endoscopic mucosal resection or endoscopic submucosal dissection
- Signed the Informed Consent Form
Exclusion
- Serious diseases that are difficult to control
- Severe hepatic and renal dysfunction
- Abnormal coagulation
- The presence of other serious physical or mental illness or laboratory abnormalities may increase the risk of participating in the study, or interfere with the results of the study, as well as the patients who the investigator believes are not suitable for participating in the study
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05300945
Start Date
January 1 2023
End Date
December 31 2028
Last Update
December 6 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.